-- Penumbra (PEN) 週一宣布，STORM-PE 隨機對照試驗的 90 天結果顯示，接受電腦輔助真空血栓切除術 (CAVT) 聯合抗凝血治療的中高危急性肺栓塞患者的功能改善程度優於僅接受抗凝血治療的患者。 在六分鐘步行試驗中，CAVT 合併抗凝血治療組的患者平均步行距離較長，達到 479 米，而僅接受抗凝血治療組為 368 米；CAVT 合併抗凝血治療組達到預測步行距離的 94%，而僅接受抗凝血治療組為 75.2%。此外，根據紐約心臟協會 (NYHA) 功能分級，CAVT 聯合抗凝血治療組報告無身體活動受限的患者比例也更高，達到 97%，而僅接受抗凝血治療組為 76%。 90 天的安全性結果在兩組之間相當，均未發生器械相關死亡，7 天後未發生其他肺栓塞相關死亡，且症狀復發率無差異。 這些數據已在介入放射學會年會上公佈。 Penumbra公司表示，關於接受CAVT治療的患者長期生活品質和功能預後的Strike-PE中期數據將於4月15日在同一會議上公佈。
Price: $330.63, Change: $+0.86, Percent Change: +0.26%
Solvar (ASX:SVR) said that the Federal Court of Australia ordered the firm's unit Money3 Loans to pay a pecuniary penalty in the sum of nearly AU$1.6 million, according to a Monday Australian bourse filing.The court's decision was in relation to the penalty payable for the contraventions of the National Consumer Credit Act during the period from 2019 to 2021."Since the period in question, Money3 has invested further in its governance, complaints, hardship, and underwriting practices," Solvar Chief Executive Scott Baldwin said.
Hangzhou Changchuan Technology (SHE:300604) posted first-quarter attributable net profit of 352.5 million yuan, up 218% from 111.0 million yuan the previous year.Earnings per share rose to 0.5472 yuan from 0.1756 yuan, according to a weekend filing with the Shenzhen bourse.Operating revenue rose 69% year over year to 1.38 billion yuan from 815.3 million yuan.Shares of the semiconductor test equipment company rose 3% in recent trade.
Dawning Information Industry's (SHA:603019) net profit attributable to shareholders in the first quarter jumped 22% to 227.8 million yuan, or 0.156 yuan per share, according to a Saturday filing on the Shanghai bourse.The supercomputer manufacturer's shares rose 2% in morning trade on Monday.Operating revenue rose 24% to 3.20 billion yuan from 2.59 billion yuan in the prior year.